Concepedia

Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-Invasive Bladder Cancer: Results of a Phase 2 Trial

Fern Anari, John P. O’Neill, Woonyoung Choi, David Y.T. Chen, Mohammed Haseebuddin, Alexander Kutikov, Essel Dulaimi, R. Katherine Alpaugh, Karthik Devarajan, Richard E. Greenberg,

European Urology Oncology · 2018 · 33 citations · 20 references

DOIFull text

Open access

Concepts

References

20

Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer

H. Barton Grossman, Ronald B. Natale, Catherine M. Tangen et al. · New England Journal of Medicine · 2003 · 2.6K citations · Full text

, , +12

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Hans von der Maase, Steen Werner Hansen, J.T. Roberts et al. · Journal of Clinical Oncology · 2000 · 2.3K citations · Full text

, , +11

Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy

Woonyoung Choi, Sima P. Porten, Seungchan Kim et al. · Cancer Cell · 2014 · 1.7K citations

, , +9

Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology

Ahmad Shabsigh, Ruslan Korets, Kinjal Vora et al. · European Urology · 2008 · 1.4K citations

, , +12

Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy

Roland Seiler, H.A.D.M. Ashab, Nicholas Erho et al. · European Urology · 2017 · 792 citations

, , +13